Data / Form D filings / Prelude Corp
Prelude Corp: Form D filings
Prelude Corp, a biotechnology company in Laguna Hills, CA, filed 6 Form D notices with the SEC between 2016 and 2025. The latest, on November 6, 2025, reports $5 million sold of a $7.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26051 MERIT CIRCLE, SUITE 102, Laguna Hills, CA, 92653
- Phone
- (949) 348-1188
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1669317
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | New notice | $7,500,000 | $5,000,000 | $2,500,000 | 1 | Oct 30, 2025 | sec.gov |
| Feb 15, 2022 | New notice | $20,000,001 | $9,281,159 | $10,718,842 | 32 | Jan 31, 2022 | sec.gov |
| Jan 10, 2020 | New notice | $10,000,013 | $10,000,013 | 7 | Dec 27, 2019 | sec.gov | |
| Jul 27, 2018 | New notice | $8,999,991 | $8,999,991 | 7 | Jul 20, 2018 | sec.gov | |
| Mar 15, 2017 | New notice | $5,499,998 | $5,499,998 | 7 | Feb 28, 2017 | sec.gov | |
| Mar 15, 2016 | New notice | $3,000,000 | $2,150,002 | $849,998 | 4 | Feb 26, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alejandro B. Sanchez | Director | |
| Gerrit B. Adams | Director | |
| Andrew B. Wade | Executive Officer | |
| Olav B. Bergheim | Executive Officer, Director | |
| Daniel B. Forche | Executive Officer, Director | |
| Derek B. Maetzold | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Prelude Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.